Literature DB >> 16893325

Prevalence of hepatitis C virus infection among men who have sex with men at a Boston community health center and its association with markers of high-risk behavior.

Daniel E Cohen1, Christopher J Russell, Sarit A Golub, Kenneth H Mayer.   

Abstract

The present study sought to investigate the prevalence of hepatitis C virus (HCV) among men who have sex with men (MSM) seen at a community health center, and to examine risk factors associated with infection. The study population included 218 MSM who were screened for HCV infection during routine clinic visits from May through December, 2001. Eighty-four percent of those screened (n = 183) agreed to complete a self-report questionnaire assessing drug use, sexual practices, and medical history. Participants ranged in age from 22 to 54 years. The majority of participants (82%) self-identified as Caucasian and 35% were HIV-positive. Prevalence of HCV infection was 11.5%. Men infected with HCV were more likely than HCV uninfected men to be coinfected with HIV and hepatitis B, and to have a history of rectal or urethral gonorrhea. HCV-infected men were more likely to have seen blood on shared cocaine straws and to have used crack cocaine in the past 6 months. Overall, 12% of HCV-infected men reported no parenteral risk factors for HCV infection. HCV seropositivity was significantly associated with an aggregate score representing high-risk behavior in the past six months. HCV prevention and screening should target MSM engaging in high-risk sex. Conversely, HIV and sexually transmitted infection risk reduction interventions should be targeted at MSM with HCV.

Entities:  

Mesh:

Year:  2006        PMID: 16893325     DOI: 10.1089/apc.2006.20.557

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  13 in total

1.  Prevalence and correlates of hepatitis C virus infection among inmates at two New York State correctional facilities.

Authors:  Kimberly J Alvarez; Montina Befus; Carolyn T A Herzig; Elaine Larson
Journal:  J Infect Public Health       Date:  2014-08-30       Impact factor: 3.718

2.  Prevalence of HCV risk behaviors among prison inmates: tattooing and injection drug use.

Authors:  Marisol Peña-Orellana; Adriana Hernández-Viver; Glorimar Caraballo-Correa; Carmen E Albizu-García
Journal:  J Health Care Poor Underserved       Date:  2011-08

Review 3.  Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis.

Authors:  L M Kucirka; H Sarathy; P Govindan; J H Wolf; T A Ellison; L J Hart; R A Montgomery; R L Ros; D L Segev
Journal:  Am J Transplant       Date:  2011-03-14       Impact factor: 8.086

4.  Discounting of delayed rewards and executive dysfunction in individuals infected with hepatitis C.

Authors:  Marilyn Huckans; Adriana Seelye; Jonathan Woodhouse; Tiffany Parcel; Lisa Mull; Daniel Schwartz; Alex Mitchell; David Lahna; Amy Johnson; Jennifer Loftis; Steven Paul Woods; Suzanne H Mitchell; William Hoffman
Journal:  J Clin Exp Neuropsychol       Date:  2010-08-06       Impact factor: 2.475

Review 5.  The potential role of biomarkers in HIV preventive vaccine trials.

Authors:  Ellen Maclachlan; Kenneth H Mayer; Ruanne Barnabas; Jorge Sanchez; Beryl Koblin; Ann Duerr
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-15       Impact factor: 3.731

6.  Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS).

Authors:  Toni Frederick; Pamela Burian; Norah Terrault; Mardge Cohen; Michael Augenbraun; Mary Young; Eric Seaberg; Jessica Justman; Alexandra M Levine; Wendy J Mack; Andrea Kovacs
Journal:  AIDS Patient Care STDS       Date:  2009-11       Impact factor: 5.078

Review 7.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

8.  Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men.

Authors:  Michelle Floris-Moore; Andrea A Howard; Yungtai Lo; Ellie E Schoenbaum; Julia H Arnsten; Robert S Klein
Journal:  AIDS Patient Care STDS       Date:  2007-07       Impact factor: 5.078

Review 9.  Scotomas in molecular virology and epidemiology of hepatitis C virus.

Authors:  Yue Wang
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

10.  Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance.

Authors:  Jessica Willner-Reid; Katherine A Belendiuk; David H Epstein; John Schmittner; Kenzie L Preston
Journal:  J Subst Abuse Treat       Date:  2007-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.